Product Safety & Liability Reporter: Current Reports Index-Summary

VACCINES

– Anthrax Vaccine Adsorbed, FDA made no clear error of judgment in approving (D.D.C.), 287
– Polio vaccine allegedly caused brain cancer, defense judgment upheld (3d Cir.), 899
– Tetanus typhoid-diptheria, injury suit dismissed when government expert more credible (Fed. Cir. Ct), 874
– Thimerosal as cause of neurological damage

– – No preemption due to conditional nature of clause (Ga.), 982
– – Preempted (Pa. Ct. Comm. Pls.), 892

– Tumor allegedly caused by polio vaccine, suit dismissed when unable to identify maker (5th Cir.), 206

VACUUM CLEANERS

– Brush attachment, TTI Floor Care N. Am recalls, laceration hazard, 721

VANS

– Defect investigations, NHTSA, 404; 530; 788
– 15-passenger vans

– – House Resolution marks intention to improve safety, 215
– – NHTSA Outlook 2008, 74
– – Rollover risk in summer months targeted in NHTSA advisory, 508

– Liftgates

– – Defect investigations, NHTSA, 788
– – Struts, Toyota recalls Sienna, 608

– Wheelchair-docking system, expert's testing did not support accident theories (Ohio Ct. App.), 779

VERMONT

– House fire allegedly caused by microwave oven, dismissing experts went beyond Daubert (Vt.), 203
– Phenergan, IV push administration, warning claim not barred (U.S., brief filed), 5; (briefs filed), 29; (rev grant), 82; Wyeth files brief, 544; government files brief, 577; brief claims Congress never meant to bar state claims, 751; medical journal editors file amicus brief against preemption, 801; Wyeth files reply brief, 926; (oral arg set), 959

VIAGRA

– Expert witnesses, MDL plaintiffs and Pfizer file Daubert motions (D. Minn.), 6; some experts allowed, other excluded, 394
– MDL lessons learned, Analysis and Perspective, 49
– N.Y. not appropriate forum for plaintiffs prescribed drugs in Cal. and Ariz. (N.Y. Sup. Ct.), 186

VIETNAM

– Agent Orange, U.S. veterans and Vietnamese cannot seek damages (3d Cir.), 207
– CPSC announces agreement, exchange aims to ensure safer imports, 272

VINYL

See POLYVINYL CHLORIDE (PVC)

VIOXX

– Blood clot, verdict reversed, evidence legally insufficient (Tex. Ct. App.), 543
– Clinical trials

– – Clinical trials deemed seeding trials designed for marketing purposes, 850
– – Guest authorship and ghostwriting case study, 400

– Damages

– – High-risk patient, award thrown out when preexisting condition not considered (Tex. Ct. App.), 490
– – N.J., punitive award vacated, compensatory award upheld, not preempted (N.J. Super. Ct.), 542; review granted (N.J.), 1022

– Heart attack and stroke MDL, Merck agrees to settle, panel discusses (E.D. La.), 26; Merck says enrollment threshold met, 237
– Marketing, state probe leads to settlement, FDA to review ads, 518
– Medical monitoring class suit thrown out due to no present injury (N.J.), 541
– N.J. courts limit remedies, Analysis and Perspective, 790

VIRGINIA

– Asbestos, whether federal maritime law rather than state law applied to shipyard worker's suit (U.S., rev. sought), 14
– NovaSure device, negligence claim against representative of device maker not preempted (W.D. Va.), 687

VISION CARE

See EYE CARE

VYTORIN

– Cancer, Dingell (D-Mich) and Stupak (D-Mich) ask makers for more information, 852
– MDL, suits consolidated (D. N.J.), 399